Gentian Diagnostics
Less than 1K followers
GENT
Oslo Børs
Medical Equipment & Services
Health Care
Overview
Investor consensus
Gentian Diagnostics is a medical diagnostics company that develops and manufactures in vitro diagnostic reagents for high-throughput analysers. Gentian’s expertise and focus lies within homogenous immunoassays, specifically infections, inflammations, kidney failures and congestive heart failures. The company headquarters and production facilities are located in Moss, Norway, serving the global human and veterinary diagnostics markets through sales and representative offices in key countries.
Read moreMarket cap
-
Turnover
-
Revenue
152.07M
EBIT %
10.34 %
P/E
-
Dividend yield-%
-
Financial calendar
11.2
2026
Annual report '25
5.5
2026
General meeting '26
6.5
2026
Interim report Q1'26
All
Press releases
ShowingAll content types
GENT: Financial calendar
GENT: Mandatory notification of trade
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools